JP2001502696A - エイズによる痴呆を処置する方法 - Google Patents

エイズによる痴呆を処置する方法

Info

Publication number
JP2001502696A
JP2001502696A JP10519635A JP51963598A JP2001502696A JP 2001502696 A JP2001502696 A JP 2001502696A JP 10519635 A JP10519635 A JP 10519635A JP 51963598 A JP51963598 A JP 51963598A JP 2001502696 A JP2001502696 A JP 2001502696A
Authority
JP
Japan
Prior art keywords
compound
effective amount
dementia due
hiv disease
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10519635A
Other languages
English (en)
Japanese (ja)
Inventor
バイマスター，フランクリン・ピー
シャノン，ハーラン・イー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JP2001502696A publication Critical patent/JP2001502696A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10519635A 1996-10-23 1997-10-23 エイズによる痴呆を処置する方法 Pending JP2001502696A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2973696P 1996-10-23 1996-10-23
US60/029,736 1996-10-23
PCT/US1997/019184 WO1998017214A1 (fr) 1996-10-23 1997-10-23 Procede de traitement d'une demence provoquee par le syndrome d'immunodeficit acquis

Publications (1)

Publication Number Publication Date
JP2001502696A true JP2001502696A (ja) 2001-02-27

Family

ID=21850604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10519635A Pending JP2001502696A (ja) 1996-10-23 1997-10-23 エイズによる痴呆を処置する方法

Country Status (5)

Country Link
EP (1) EP0934040A1 (fr)
JP (1) JP2001502696A (fr)
AU (1) AU4995797A (fr)
CA (1) CA2269506A1 (fr)
WO (1) WO1998017214A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032185A1 (fr) * 1998-11-27 2000-06-08 Sanochemia Pharmazeutika Aktiengesellschaft Utilisation d'effecteurs du systeme nerveux cholinergique central pour le traitement du delirium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826843A (en) * 1985-07-08 1989-05-02 Bristol-Myers Cerebral function enhancing diazinylpiperidine derivatives
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use

Also Published As

Publication number Publication date
WO1998017214A1 (fr) 1998-04-30
EP0934040A1 (fr) 1999-08-11
CA2269506A1 (fr) 1998-04-30
AU4995797A (en) 1998-05-15

Similar Documents

Publication Publication Date Title
EP1244456B1 (fr) Derive de pyrrolidine acetamide pour traiter des affections de douleurs chroniques et neuropathiques
JP2003510273A (ja) 神経障害性の疼痛の治療のためのレチガビンの使用
MX2012001814A (es) Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso.
US20230096920A1 (en) Treatment of demyelinating diseases
JPH07149639A (ja) （Ｓ）−（−）−α−エチル−２−オキソ−１−ピロリジ ンアセトアミドを用いる不安の治療法
CA2279498C (fr) Utilisation de la levobupivacaine en chirurgie infantile
JP2001500113A (ja) 精神遅滞を処置する方法
US4719212A (en) Therapeutic agent for memory disturbance
KR20010102219A (ko) 알쯔하이머성 치매를 치료하기 위한 데스옥시페가닌의 용도
WO1998046226A1 (fr) Traitement de la schizophrenie
JPH11514654A (ja) 外傷による脳損傷の治療方法
US6117890A (en) Method for treating bipolar disorder
EP1267849B1 (fr) Substances diminuant la reapparition de l'usage de drogues
JP2001502696A (ja) エイズによる痴呆を処置する方法
EP0821955B1 (fr) Utilisation de la 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tétrahydro-1-méthylpyridine (xanoméline) pour traiter les troubles bipolaires
CZ355998A3 (cs) Pyridil a pyrimidylpiperaziny pro léčení poruch způsobených odejmutím drogy
JP2001523724A (ja) 運動ニューロン病および脱髄病を治療するためのシチコリン
EP1274423A1 (fr) Medicament pour traiter des traumatismes cerebraux et d'autres troubles neuronaux
RU2805061C2 (ru) Лечение демиелинизирующих заболеваний
JP6126134B2 (ja) 線維筋痛症および慢性疲労症候群の治療のための、（１ｒ，４ｒ）−６’−フルオロ−（Ｎ−メチル−またはＮ，Ｎ−ジメチル−）−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミン
WO1997044062A1 (fr) Utilisation d'agonistes de 5-ht1b/1d dans le traitement de douleurs oculaires
JP2000515865A (ja) 過剰攻撃を処置する方法
JP3381198B2 (ja) １，４−ジヒドロピリジンの糖尿病における使用
JP2000516213A (ja) 破壊的行動障害を処置する方法
US20220362202A1 (en) Drug For Treating And Preventing Dementia